Abbott Laboratories (NYSE:ABT) Q3 2025 Earnings Call October 15, 2025 09:00 AM ET Company ParticipantsRobert Ford - Chairman and CEOMike Comilla - VP of Investor RelationsPhil Boudreau - EVP, Finance and CFOTravis Steed - Managing Director and Equity Research of Medical TechnologyDavid Roman - Managing DirectorConference Call ParticipantsLarry Biegelsen - Senior AnalystJosh Jennings - Senior Research AnalystDanielle Antalffy - Senior AnalystSuraj Kalia - Managing Director and Senior Analyst of Medical Techn ...

Abbott Laboratories (NYSE:ABT) Q3 2025 Earnings Call October 15, 2025 09:00 AM ET Company ParticipantsRobert Ford - Chairman and CEOMike Comilla - VP of Investor RelationsPhil Boudreau - EVP, Finance and CFOTravis Steed - Managing Director and Equity Research of Medical TechnologyDavid Roman - Managing DirectorConference Call ParticipantsLarry Biegelsen - Senior AnalystJosh Jennings - Senior Research AnalystDanielle Antalffy - Senior AnalystSuraj Kalia - Managing Director and Senior Analyst of Medical Techn ...

Abbott Laboratories (NYSE:ABT) Q3 2025 Earnings Call October 15, 2025 09:00 AM ET Speaker0Good morning, and thank you for standing by. Welcome to Abbott's Third Quarter twenty twenty five Earnings Conference Call. All participants will be able to listen only until the question and answer portion of this call. During the question and answer session, you will be able to ask your question by pressing the star one one keys on your touch tone phone. This call is being recorded by Abbott.With the exception of any ...

Abbott Laboratories (NYSE:ABT) Q3 2025 Earnings Call October 15, 2025 09:00 AM ET Speaker4Good morning and thank you for standing by. Welcome to Abbott Laboratories' third quarter 2025 earnings conference call. All participants will be able to listen only until the question and answer portion of this call. During the question and answer session, you will be able to ask your question by pressing the star one one keys on your touchtone phone. This call is being recorded by Abbott Laboratories. With the except ...

Key Points Abbott Labs is a well-established medical device giant with a robust, diversified business. The healthcare giant has an incredible innovative streak that has allowed it to remain a leader. Abbott is also a dividend powerhouse, having increased its payout for 53 consecutive years. 10 stocks we like better than Abbott Laboratories › There are significant advantages to holding shares of companies for a long time as opposed to, say, day trading. The buy-and-hold approach is simpler, doesn' ...

MINNEAPOLIS and BRISBANE, Australia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, announced today it has received regulatory clearance from the Danish Medicines Agency to initiate the DurAVR® Transcatheter Heart Valve (THV) global pivotal trial in patients with severe calcific aortic s ...

OAK RIDGE, Tenn., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the MedAxiom Cardiovascular (CV) Transforum Fall’25 Conference being held at the JW Marriott Austin, from Thursday, October 16 - Saturday, October 18 in Austin, TX. The CV Transforum is the leading conference for cardiovascular organizational performance solutions, uniting industry innovators and thought leaders from across th ...

Abbott cut the top end of its 2025 earnings guidance by 2 cents a share, just as the Trump administration launched an investigation into the medical device sector https://t.co/R5qPn9BmKV ...

(Reuters) -Abbott's quarterly revenue fell short of analysts' expectations on Wednesday, as weakness in its diagnostics and nutritional businesses failed to offset strong demand for its medical devices. Shares of the company dropped nearly 3% premarket following the results. Abbott's total revenue of $11.37 billion, slightly missed analysts' average estimate of $11.40 billion, according to data compiled by LSEG. Sales in its diagnostics segment fell 6.6% to $2.25 billion, missing the estimate of $2.29 b ...

Abbott reported higher quarterly revenue on Wednesday, driven by strong demand for its medical devices including continuous glucose monitors and heart devices. ...